Health Care & Life Sciences » Pharmaceuticals | Endo International PLC

Endo International PLC | Mutual Funds

Mutual Funds that own Endo International PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Core S&P Small Cap ETF
11,100,725
4.96%
3,144
0.4%
09/06/2018
Vanguard Total Stock Market Index Fund
5,070,937
2.25%
54,296
0.01%
07/31/2018
Vanguard Small Cap Index Fund
5,066,340
2.25%
65,494
0.09%
07/31/2018
iShares Russell 2000 ETF
4,719,750
2.11%
-2,520
0.17%
09/06/2018
AST Prudential Growth Allocation Portfolio
3,402,500
1.52%
-223,100
0.25%
03/29/2018
iShares S&P Small Cap 600 Value ETF
3,208,374
1.43%
3,922
0.78%
09/06/2018
Vanguard Small Cap Value Index Fund
3,181,469
1.42%
34,986
0.17%
07/31/2018
DFA US Small Cap Value Portfolio
2,871,294
1.28%
89,422
0.24%
04/30/2018
Vanguard Extended Market Index Fund
2,663,023
1.19%
46
0.06%
07/31/2018
iShares Nasdaq Biotechnology ETF
2,587,663
1.15%
-33,831
0.45%
09/06/2018

About Endo International

View Profile
Address
Minerva House
Dublin Dublin 4
Ireland
Employees -
Website http://www.endo.com
Updated 07/08/2019
Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.